Many women do not follow the recommended guidelines to avoid contraception for 18-months after bariatric surgery.
In a study led by Northwestern University Feinberg School of Medicine and the Translational Genomics Research Institute (TGen), this anti-cancer agent is being considered for use against glioblastoma multiforme (GBM), the most common and aggressive type of deadly brain tumors. The study was published today in Molecular Cancer Research, a journal of the American Association for Cancer Research (AACR).
Scientists have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells.
One of the two brain-training methods most scientists use in research is significantly better in improving memory and attention. It also results in more significant changes in brain activity.
Taking advantage of its special expertise in identifying tick-borne, disease-causing pathogens, plus its access the thousands of people who send ticks to be tested each year, the LMZ at UMass Amherst will partner with with L2 Diagnostics of New Haven, a biotech company that has developed a human test for Borrelia miyamotoi, one of the latest tick pathogens to emerge.
Testing and targeting treatment on a patient's virtual heart could lead to longer and healthier lives, especially for the 5.7 million adults with heart failure. Two University of Kentucky researchers are working to make this a reality.
The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Seven Bridges, the leading biomedical data analysis company, today announced a new collaboration to build an NCI-funded data platform to accelerate translational research using patient-derived tumor xenograft (PDX) datasets.
One of the largest and best-documented trials of children receiving early antiretroviral therapy -- the CHER clinical trial in South Africa -- finds ongoing white matter damage in HIV-positive children at the age of 7 years. The study aims to contribute to a better understanding of brain development in HIV-infected and exposed children, as well as the impact of long-term antiretroviral treatment.
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning. Published in PLOS Pathogens, the studies from Professor Ethan Bier's laboratory used a series of experiments to identify key pathways and mechanisms previously unknown or overlooked in the body's defenses, and possible treatments already developed.
Massachusetts General Hospital investigators have identified differences in gene transcription within key immune cells that may distinguish those individuals infected with the hepatitis C virus who develop chronic infection from those whose immune systems successfully clear the virus.